<PAGE>
                                
         UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                                
                      WASHINGTON, DC  20549
                                
                                
                            FORM 10-Q
                                
   (MARK ONE) QUARTERLY REPORT / X / OR TRANSITION REPORT /  /
               PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934



For the quarter ended
January 31, 1999                       Commission File No. 1-5865



                     GERBER SCIENTIFIC, INC.
                ---------------------------------
                   (Exact name of Registrant as
                    specified in its charter)



           CONNECTICUT                             06-0640743
 -------------------------------              ---------------------
 (State or other jurisdiction of                  (IRS Employer
  incorporation or organization)               Identification No.)


 83 Gerber Road West, South Windsor, Connecticut       06074
------------------------------------------------- ---------------
    (Address of principal executive offices)         (Zip Code)
                                                          
                                                          
                                                          
Registrant's Telephone Number, including area      (860) 644-1551
code                                              ---------------


Indicate  by check mark whether the registrant (1) has filed  all
reports  required  to be filed by Section  13  or  15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports)  and  (2) has been subject  to  such  filing
requirements for the past 90 days.


                      Yes  / X /.   No /    /.

At  January  31, 1999, 22,662,326 shares of common stock  of  the
Registrant were outstanding.

<PAGE 1>

                     GERBER SCIENTIFIC, INC.
                        AND SUBSIDIARIES
            CONTENTS OF QUARTERLY REPORT ON FORM 10-Q
                                
                 Quarter Ended January 31, 1999


                                                             PAGE



Part I - Financial Information

  Item 1. Consolidated Financial Statements:

           Statement of Earnings for the three months
           ended January 31, 1999 and 1998                   2
           
           Statement of Earnings for the nine months
           ended January 31, 1999 and 1998                   3
           
           Balance Sheet at January 31, 1999 and
           April 30, 1998                                  4-5
           
           Statement of Cash Flows for the nine months
           ended January 31, 1999 and 1998                   6
           
           Notes to Financial Statements                     7
           
           Independent Accountants' Report                  13

  Item 2. Management's Discussion and Analysis of
           Financial Condition and Results of Operations    14


Part II - Other Information

  Item 6. Exhibits and Reports on Form 8-K                  20


Signature                                                   21


Exhibit Index                                               22

<PAGE 2>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENT OF EARNINGS

------------------------------------------------------------
                                         In thousands
                                  (except per share amounts)
------------------------------------------------------------
Three Months Ended January 31,             1999       1998
------------------------------------------------------------
                                                    
Revenue:                                            
                                                    
  Product sales                         $128,852     $92,559
  Service                                 11,947      12,277
                                         -------     -------
                                         140,799     104,836
                                         -------     -------
                                                            
Costs and Expenses:                                         
                                                            
  Cost of product sales                   74,159      48,743
  Cost of service                          7,250       7,301
  Selling, general and administrative     38,837      32,219
  Research and development expenses        7,682       7,746
                                         -------     -------
                                         127,928      96,009
                                         -------     -------
                                                            
Operating income                          12,871       8,827
                                                            
Other income                                 478         378
Interest expense                         (2,604)         (90)
                                         -------     -------
                                                            
Earnings before income taxes              10,745       9,115
                                                            
Provision for income taxes                 3,700       2,900
                                         -------     -------
                                                
Net earnings                            $  7,045     $ 6,215
                                         =======     =======
                                                            
Per share of common stock:                                  
  Basic                                 $    .31     $   .28
  Diluted                               $    .31     $   .27
                                                            
  Dividends                             $    .08     $   .08
                                                            
Average shares outstanding:                                 
  Basic                                   22,700      22,586
  Diluted                                 23,058      23,025
                                                            
                     See Accompanying Notes

<PAGE 3>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENT OF EARNINGS

------------------------------------------------------------
                                         In thousands
                                  (except per share amounts)
------------------------------------------------------------
Nine Months Ended January 31,              1999       1998
------------------------------------------------------------
                                                    
Revenue:                                            
                                                    
  Product sales                         $409,010    $274,703
  Service                                 36,038      35,486
                                         -------     -------
                                         445,048     310,189
                                         -------     -------
                                                            
Costs and Expenses:                                         
                                                            
  Cost of product sales                  239,296     148,623
  Cost of service                         21,270      22,681
  Selling, general and administrative    120,186      94,926
  Research and development expenses       22,955      23,099
                                         -------     -------
                                         403,707     289,329
                                         -------     -------
                                                            
Operating income                          41,341      20,860
                                                            
Other income                               1,675       3,388
Interest expense                          (9,114)       (266)
                                         -------     -------
                                                            
Earnings before income taxes              33,902      23,982
                                                            
Provision for income taxes                12,400       7,700
                                         -------     -------
                                                
Net earnings                            $ 21,502    $ 16,282
                                         =======     =======
                                                            
Per share of common stock:                                  
  Basic                                 $    .95    $    .71
  Diluted                               $    .93    $    .70
                                                            
  Dividends                             $    .24    $    .24
                                                            
Average shares outstanding:                                 
  Basic                                   22,721      22,863
  Diluted                                 23,213      23,354
                                                            

                     See Accompanying Notes

<PAGE 4-5>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                   CONSOLIDATED BALANCE SHEET
                                
                                
                                             In thousands
 --------------------------------------------------------------
                                        January 31,  April 30,
                                           1999         1998
 --------------------------------------------------------------
                            Assets
Current Assets:                                      
 Cash and short-term cash investments     $ 16,884    $ 27,007
 Accounts receivable                       109,395      79,114
 Inventories                                80,663      61,111
 Prepaid expenses                           11,440      18,227
                                          --------    --------
                                           218,382     185,459
                                          --------    --------
Property, Plant and Equipment              149,407     117,334
 Less accumulated depreciation              63,179      57,335
                                          --------    --------
                                            86,228      59,999
                                          --------    --------
                                                              
Intangible Assets                          240,560      99,463
 Less accumulated amortization              15,615       8,208
                                          --------    --------
                                           224,945      91,255
                                          --------    --------
Other Assets                                 1,852       2,054
                                          --------    --------
                                          $531,407    $338,767
                                          ========    ========

             Liabilities and Shareholders' Equity
                                                              

Current Liabilities:                                           
 Notes payable                            $     --    $    326
 Current maturities of long-term debt          193         193
 Accounts payable                           41,008      30,462
 Accrued compensation and benefits          17,785      17,253
 Other accrued liabilities                  34,467      30,347
 Deferred revenue                            7,265       6,619
 Advances on sales contracts                 5,837       5,498
                                          --------    --------
                                           106,555      90,698
                                          --------    --------
Noncurrent Liabilities:                                       
 Deferred income taxes                      10,036      10,202
 Long-term debt                            170,535       6,953
                                          --------    --------
                                           180,571      17,155
                                          --------    --------

Contingencies and Commitments                        
                                                     
Shareholders' Equity:                                
 Preferred stock, no par value;                                
  authorized 10,000,000 shares; no                             
  shares issued                                 --           --
 Common stock, $1.00 par value;                                
  authorized 65,000,000 shares; issued                         
  23,462,326 and 23,436,523 shares          23,462       23,437
 Paid-in capital                            40,344       37,779
 Retained earnings                         199,554      187,981
 Accumulated other comprehensive loss                          
  (foreign currency translation                                
  adjustment)                              (2,157)       (1,833)
 Unamortized value of restricted stock                         
  grants                                     (472)           --
 Treasury stock, at cost (800,000                              
shares)                                   (16,450)      (16,450)
                                          --------     --------
                                           244,281      230,914
                                          --------     --------
                                          $531,407     $338,767
                                          ========     ========

                     See Accompanying Notes

<PAGE 6>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
              CONSOLIDATED STATEMENT OF CASH FLOWS
                                                    In thousands
---------------------------------------------------------------------
Nine Months Ended January 31,                     1999         1998
---------------------------------------------------------------------
CASH PROVIDED BY (USED FOR):                                         
                                                                     
Operating Activities                                                 
  Net earnings                                  $21,502     $ 16,282        
  Adjustments to reconcile net earnings to                          
   cash provided by operating activities:              
     Depreciation and amortization               17,809        9,655
     Deferred income taxes                         (382)         494
     Other non-cash items                           178           --
     Changes in operating accounts, net of                          
      effects of business acquisitions:
      Receivables                                (6,963)        (778)
      Inventories                                 7,322       (8,299)
      Prepaid expenses                            9,060          291
      Accounts payable and accrued expenses     (10,901)      16,150
                                               --------     --------
Provided by Operating Activities                 37,625       33,795
                                               --------     --------
Financing Activities                                                
  Purchase of common stock                       (4,940)     (16,450)
  Additions of long-term debt                   186,686           --
  Repayments of long-term debt                  (24,445)        (143)
  Net short-term financing                      (11,963)          --
  Debt issue costs                                 (800)          --
  Exercise of stock options                       2,602          993
  Dividends on common stock                      (5,458)      (5,477)
                                               --------     --------
Provided by (Used for) Financing Activities     141,682      (21,077)
                                               --------     --------
Investing Activities                                                
  Maturities of long-term debt securities            --       19,378
  Additions to property, plant and equipment    (14,369)     (13,109)
  Business acquisitions                        (175,952)          --
  Intangible and other assets                      (222)          52
  Other, net                                      1,113       (2,799)
                                               --------     --------         
Provided by (Used for) Investing Activities    (189,430)       3,522
                                               --------     --------
                                                                    
Increase (Decrease) in Cash and Short-Term                          
  Cash Investments                              (10,123)      16,240
                                                                    
Cash and Short-Term Cash Investments,                               
  Beginning of Period                            27,007        9,503
                                               --------     --------
                                                                    
Cash and Short-Term Cash Investments,          $ 16,884     $ 25,743
  End of Period                                ========     ========
                     See Accompanying Notes

<PAGE 7>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1

The   consolidated  balance  sheet  at  January  31,  1999,   the
consolidated statements of earnings for the three- and nine-month
periods  ended  January 31, 1999 and 1998, and  the  consolidated
statement of cash flows for the nine-month periods ended  January
31,  1999  and  1998  are unaudited but, in the  opinion  of  the
Company,  include  all  adjustments, consisting  only  of  normal
recurring accruals, necessary for a fair statement of the results
for the interim periods.  The results of operations for the nine-
month   period  ended  January  31,  1999  are  not   necessarily
indicative  of  the results to be expected for  the  full  fiscal
year.

NOTE 2

The classification of inventories was as follows (in thousands):

                      January 31, 1999    April 30, 1998
                      ----------------   ---------------
Raw materials and                                       
  purchased parts              $47,675           $37,329
Work in process                 32,988            23,782
                               -------           -------
                               $80,663           $61,111
                               =======           =======

NOTE 3

In February 1997, the Financial Accounting Standards Board issued
Statement  of  Financial  Accounting Standards  (SFAS)  No.  128,
"Earnings Per Share," effective for financial statements for both
annual  and interim periods ending after December 15, 1997.  SFAS
No.  128  replaced  the  previously reported  primary  and  fully
diluted  earnings per share with basic and diluted  earnings  per
share.   Unlike  primary earnings per share, basic  earnings  per
share  excludes  any dilutive effects of options,  warrants,  and
convertible securities.  Diluted earnings per share is similar to
the  previously reported fully diluted earnings per  share.   All
earnings  per share amounts for all periods have been  presented,
and  where  necessary restated, to conform to the  SFAS  No.  128
requirements.  This restatement had an immaterial impact  on  the
prior  period  earnings  per  share amounts  under  the  previous
method.

<PAGE 8>

The  following  table  sets forth the computation  of  basic  and
diluted earnings per share:

                            Three Months             Nine Months
                         Ended January 31,        Ended January 31,
                         -----------------        -----------------
                         1999         1998        1999         1998
                        -------      -------     -------      -------
Numerator:                                                             
 Net income           $ 7,045,000  $ 6,215,000  $21,502,000 $16,282,000
                        =========    =========   ==========  ==========
Denominators:                                                          
 Denominators for                                                      
  basic earnings per                                                   
  share--weighted-                                                     
  average shares                                                       
  outstanding          22,699,682   22,585,845  22,720,640   22,863,194
 Effect of dilutive                                                    
  securities:                                                          
  Employee stock                                                       
   options                358,573      438,662     492,430      490,619
                       ----------   ----------  ----------   ----------
  Denominator for                                                      
   diluted earnings                                                    
   per share--                                                         
   adjusted                                                            
   weighted-average                                                    
   shares                                                              
   outstanding         23,058,255   23,024,507  23,213,070   23,353,813
                       ==========   ==========  ==========   ==========
Basic earnings per                                                     
 share                $       .31  $       .28 $       .95  $       .71
                       ==========   ==========  ==========   ==========
Diluted earnings per                                                   
 share                $       .31  $       .27 $       .93  $       .70
                       ==========   ==========  ==========   ==========

NOTE 4

Beginning  in  the first quarter of FY 1999, the Company  adopted
SFAS No. 130, "Reporting Comprehensive Income," which established
standards  for reporting and displaying comprehensive income  and
its  components in an annual financial statement  with  the  same
prominence  as  other financial statements.  This statement  also
requires  that an entity report a total for comprehensive  income
in condensed financial statements of interim periods.

The  Company's  total comprehensive income  was  as  follows  (in
thousands):

<PAGE 9>

                           Three Months Ended   Nine Months Ended
                               January 31,         January 31,
                             1999      1998       1999      1998
                           -------    -------   -------   -------
Net income                   $7,045    $6,215    $21,502   $16,282
Other comprehensive                                               
 income (loss):                                         
  Foreign currency                                                
   translation                                                    
     adjustments              1,511    (1,675)      (324)   (2,799)
                             ------    ------     ------    ------
  Total comprehensive                                             
   income                    $8,556    $4,540    $21,178   $13,483
                              =====     =====     ======    ======


NOTE 5

In  June of 1998, the Financial Accounting Standards Board issued
SFAS  No. 133, "Accounting for Derivative Instruments and Hedging
Activities," which must be adopted by May 1, 2000.   The  Company
is  evaluating the impact of the new requirement.  At this  time,
management  does  not  expect implementation  will  result  in  a
material  impact on the Company's financial position, results  of
operations, or cash flows.

Effective  May  1,  1998,  the  Company  adopted  SFAS  No.  131,
"Disclosures  about  Segments  of  an  Enterprise   and   Related
Information."   This  standard  changes  the  criteria  used   to
determine  the  segments  for which SEC registrants  must  report
information.   As  permitted by the standard,  the  Company  will
provide the required disclosures for its segments in its Form 10-
K for the year ending April 30, 1999.

Effective  May  1,  1998,  the  Company  adopted  SFAS  No.  132,
"Employers' Disclosures about Pensions and Other Post  Retirement
Benefits."   This  statement requires  additional  disclosure  on
changes in the benefit obligations and fair values of plan assets
during the year.  As permitted by the standard, the Company  will
provide  the  required disclosures for its benefit plans  in  its
Form 10-K for the year ending April 30, 1999.

NOTE 6

Included  in  other  income  for  the  nine-month  period   ended
January  31, 1998 was a gain resulting from the final  settlement
of  the Company's UK patent litigation with Lectra Systemes, S.A.
of France, which added $1,563,000 to earnings before income taxes
and  approximately $1,000,000, or $.04 per diluted share, to  net
income.

<PAGE 10>

NOTE 7

On  February  27,  1998, Gerber Optical,  Inc.,  a  wholly  owned
subsidiary  of  the  Company, acquired the outstanding  stock  of
Coburn  Optical Industries, Inc. (Coburn) of Muskogee,  Oklahoma,
and  subsequently  merged with Coburn.  The company  was  renamed
Gerber  Coburn Optical, Inc. (GC).  The purchase price, including
the   costs   of  acquisition  and  the  repayment  of   Coburn's
outstanding  debt, was approximately $63,000,000.  Coburn  was  a
leading  manufacturer and international distributor  of  a  broad
range   of  ophthalmic  lens  processing  equipment  and  related
supplies  used  in  the production of eyeglass  lenses.   GC  has
continued to develop, manufacture, market, and support the Coburn
product lines.

On  May  5, 1998, the Company announced the successful completion
of  its  cash tender offer for the outstanding capital  stock  of
Spandex  PLC  (Spandex) of Bristol, UK.  Spandex was the  largest
distributor of equipment and related materials to the sign making
industry in Europe and North America. The offer valued Spandex at
approximately    $173,000,000.   In   addition,    Spandex    had
approximately $11,600,000 in outstanding debt that was assumed.

Each  acquisition was accounted for as a purchase and the results
of operations of the acquired companies have been included in the
Company's consolidated statements of earnings from the respective
dates  of  acquisition.  The acquisition costs were allocated  to
the assets and liabilities acquired based upon their fair values.
The  excess of acquisition costs over the fair values of the  net
assets acquired was included in intangible assets as goodwill and
is  being  amortized on a straight-line basis over 25 years  from
the date of acquisition.

The  following pro forma combined results of operations  for  the
three-  and nine-month periods ended January 31, 1998  have  been
prepared  as  if the Coburn and Spandex acquisitions occurred  at
May  1, 1997 and give effect to estimated purchase accounting and
other adjustments resulting from the acquisitions.  The pro forma
information  is presented on the assumption that the  acquisition
costs  would  have been the same at May 1, 1997.  The  pro  forma
financial  information  is  not  necessarily  indicative  of  the
results  of  operations  that would have been  achieved  had  the
acquisitions of Coburn and Spandex actually been effective as  of
May 1, 1997 or of future results of the combined companies.

<PAGE 11>

                           (Unaudited)           (Unaudited)
                         ---------------        -------------
                       Three Months Ended     Nine Months Ended
                           January 31,           January 31,
                       ------------------    -------------------
In thousands                                                   
(except per share                                              
 amounts)                     1998                  1998
--------------------   ------------------   -------------------
Sales                            $159,864              $478,885
Net earnings                        6,469                17,355
Net earnings per                                               
 common share-basic                   .29                   .76
Net earnings per                                               
 common share-diluted                 .28                   .74

<PAGE 12>
                                                                 
            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES




With  respect to the unaudited consolidated financial  statements
of  Gerber Scientific, Inc. and subsidiaries at January 31,  1999
and  for the three- and nine-month periods ended January 31, 1999
and 1998, KPMG LLP has made a review (based on procedures adopted
by  the  American Institute of Certified Public Accountants)  and
not  an  audit,  as  set  forth in their  separate  report  dated
February  17,  1999 appearing on page 13.  That report  does  not
express   an   opinion  on  the  interim  unaudited  consolidated
financial  information.   KPMG  LLP  has  not  carried  out   any
significant  or additional audit tests beyond those  which  would
have  been  necessary  if  their report had  not  been  included.
Accordingly,  such  report  is not a "report"  or  "part  of  the
Registration Statement" within the meaning of Sections 7  and  11
of  the  Securities Act of 1933 and the liability  provisions  of
Section 11 of such Act do not apply.

<PAGE 13>

                 INDEPENDENT ACCOUNTANTS' REPORT


To the Board of Directors and Shareholders of
Gerber Scientific, Inc.


We  have made a review of the consolidated statements of earnings
of  Gerber  Scientific, Inc. and subsidiaries for the three-  and
nine-month  periods  ended  January  31,  1999  and   1998,   the
consolidated  statement of cash flows for the nine-month  periods
ended  January  31,  1999 and 1998, and the consolidated  balance
sheet  as  of  January  31,  1999 in  accordance  with  standards
established  by  the  American  Institute  of  Certified   Public
Accountants.   We  have previously audited,  in  accordance  with
generally   accepted  auditing  standards,  and   expressed   our
unqualified  opinion  dated  May 21,  1998  on  the  consolidated
financial  statements  for the year ended  April  30,  1998  (not
presented  herein).  The aforementioned financial statements  are
the responsibility of the Company's management.

A review of interim financial information consists principally of
applying  analytical  review procedures  to  financial  data  and
making  inquiries  of  persons  responsible  for  financial   and
accounting  matters.  It is substantially less in scope  than  an
examination  in  accordance  with  generally  accepted   auditing
standards, the objective of which is the expression of an opinion
regarding   the   financial  statements   taken   as   a   whole.
Accordingly, we do not express such an opinion.

Based   on   our  review,  we  are  not  aware  of  any  material
modifications   that   should  be  made   to   the   accompanying
consolidated statements of earnings for the three- and nine-month
periods  ended  January  31,  1999  and  1998,  the  consolidated
statement of cash flows for the nine-month periods ended  January
31,  1999  and  1998,  or the consolidated balance  sheet  as  of
January  31,  1999  for them to be in conformity  with  generally
accepted   accounting  principles.  Also,  in  our  opinion   the
information in the accompanying consolidated balance sheet as  of
April 30, 1998 is fairly presented, in all material respects,  in
relation to the consolidated balance sheet from which it has been
derived.




/ s / KPMG LLP


Hartford, Connecticut
February 17, 1999

<PAGE 14>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
             MANAGEMENT'S DISCUSSION AND ANALYSIS OF
          FINANCIAL CONDITION AND RESULTS OF OPERATIONS


OVERVIEW

In  May  1998,  the  Company acquired the  outstanding  stock  of
Spandex PLC (Spandex).  Accordingly, Spandex was included in  the
Company's consolidated balance sheet at January 31, 1999, in  the
Company's  results from operations for the three- and  nine-month
periods  ended January 31, 1999, and in the Company's cash  flows
for the nine-month period ended January 31, 1999.

In  February 1998, the Company acquired the outstanding stock  of
Coburn Optical Industries, Inc. (Coburn).  Coburn was included in
the  Company's consolidated balance sheet at April 30,  1998,  in
the  Company's results from operations for the three-  and  nine-
month  periods ended January 31, 1999, and in the Company's  cash
flows for the nine-month period ended January 31, 1999.

In  March  1998, the Company sold its Gerber Systems unit,  which
comprised  the  Company's imaging and inspection systems  product
class.   As  a  result, the Company's April 30, 1998 consolidated
balance  sheet  and  the fiscal year 1999 consolidated  financial
statements do not include any Gerber Systems activity.

FINANCIAL CONDITION

The  Company's ratio of current assets to current liabilities was
2.0  to  1  at January 31, 1999 and April 30, 1998.  Net  working
capital  at  January 31, 1999 was $111.8 million, an increase  of
$17.1  million from the beginning of the current fiscal year  and
largely  attributable to the Spandex acquisition.  The  Company's
cash  and  investments totaled $16.9 million at January 31,  1999
compared with $27 million at the end of the prior fiscal year.

Operating activities provided $37.6 million in cash for the nine-
month  period ended January 31, 1999 compared with $33.8  million
provided  by operating activities for the same period last  year.
Cash  in  this year's first nine months was generated by earnings
and the non-cash charges for depreciation and amortization, lower
inventory balances, and a tax refund resulting from the  sale  of
the  Company's imaging and inspection systems product class. Cash
generated from operations was somewhat offset by higher  accounts
receivable  balances caused by the higher volume of business  and
lower  accounts  payable  and accrued  liabilities  balances  due
largely to the timing of vendor payments.

The  principal non-operating use of cash in the nine months ended
January  31,  1999  was for the purchase of  Spandex  for  $187.6
million,  which included the repayment of its debt. The financing
for  the  acquisition was provided primarily by  a  $235  million
revolving multi-currency credit facility the Company entered into

<PAGE 15>

with a group of major U.S., European, and Asian commercial banks.
Other non-operating uses of cash in the nine months ended January
31,  1999  were  repayments of long-term debt of  $24.4  million,
additions to property, plant, and equipment of $14.4 million, and
payment  of  dividends of $5.5 million.  The Company  anticipates
that capital expenditures for the current fiscal year will be  in
the  range of $20-$22 million and expects to fund these with cash
on hand and cash from operations.

Another significant non-operating use of cash in the nine  months
ended  January  31,  1999  was  for the  Company's  common  stock
repurchase  program.  In November 1998, the  Board  of  Directors
authorized  a  new stock repurchase program for up  to  3,000,000
shares, or approximately 13 percent, of the Company's then-issued
and  outstanding  common  stock.  As of  January  31,  1999,  the
Company  had repurchased 239,100 shares, of which 107,900  shares
were  under  the  new  authorization and 131,200  were  under  an
earlier authorization.  The cost of these shares was $5.1 million
(of  which $4.9 million was paid as of January 31, 1999),  or  an
average  cost  of  $21.35  per share.  Under  the  authorization,
management  of  the Company has discretion to purchase  stock  as
market conditions warrant.

The  Company's total debt at January 31, 1999 was $170.7 million,
which  was  up substantially from the April 30, 1998  balance  of
$7.5  million and caused by the acquisition of Spandex. Net  debt
(total  debt  less  cash and investments) was $153.8  million  at
January  31, 1999 versus a net cash position of $19.5 million  at
April 30, 1998.  The ratio of net debt to total capital was  38.6
percent at January 31, 1999.

RESULTS OF OPERATIONS

Combined  sales and service revenue for the three- and nine-month
periods  ended  January  31,  1999 increased  $36  million  (34.3
percent)  and  $134.9 million (43.5 percent), respectively,  from
the  same  periods  last  year.  The  increase  reflected  higher
product  sales,  predominantly from the acquisitions  of  Spandex
(increases of $35.6 million and $117.4 million in sales for three-
and   nine-month  periods  ended  January  31,   1999,   net   of
intercompany eliminations, respectively) and Coburn (increases of
$14.3  million and $48 million in sales for the three- and  nine-
month periods ended January 31, 1999, respectively). The sale  of
the Company's imaging and inspection system product class in last
year's fourth quarter was an offsetting factor ($9.6 million  and
$32.4 million in sales in the three- and nine-month periods ended
January 31, 1998).

Adjusting for the business acquisitions and divestiture, combined
sales  and service revenue was lower in this year's third quarter
and  higher in this year's first nine months from the comparable
periods last year.   The decrease in  the  quarter  was  caused
predominantly  by lower sales of the Company's automated  cutting
equipment in certain international markets (particularly  Turkey,

<PAGE 16>

Southeast  Asia,  and Brazil).  The year-to-date  revenue  growth
came  predominantly  from higher sales of the  Company's  optical
lens manufacturing systems.

Recently,  the Company also experienced weakness in  its  optical
lens manufacturing systems business, which was caused by softness
in  the prescription optical lens business, consolidation in both
the  retail  and wholesale segments of the industry,  and,  to  a
lesser  extent, the economic softness in Brazil.   The  Company's
management  took  immediate action to  resize  its  optical  lens
manufacturing  business to account for the  lower  volume,  which
included reducing employee headcount and other initiatives. These
actions  are intended to eliminate approximately $8 million  from
costs and expenses next fiscal year.

Service  revenue increased $1.5 million (14.6 percent)  and  $5.6
million  (18.3  percent) from the prior year's three-  and  nine-
month   periods  ended  January  31,  1998,  respectively,  after
adjusting  for  the elimination of the service revenue  from  the
imaging  and  inspection systems products.  These increases  were
caused  by growth in the Company's service operations and by  the
acquisitions of Spandex and Coburn.

The  consolidated gross profit margin in this year's  first  nine
months  was  41.5 percent, which was lower than  the  prior  year
margin  of  44.8 percent.  Gross profit margins on product  sales
were  lower, while service margins were higher.  The decrease  in
product  gross  profit  margins  was  related  primarily  to  the
inclusion  of  Spandex in the Company's financial  statements  in
fiscal  year  1999.  As a distributor, Spandex  historically  had
gross  profit  margins substantially lower  than  the  Company's.
However,    Spandex's   historical   operating    margins    were
incrementally higher than the Company's recent operating margins,
owing  in  part  to  the  absence of  spending  on  research  and
development.  Also reducing the comparative product gross  profit
margins  in  this year's third quarter and first nine months  was
the  inclusion of Coburn. A larger percentage of Coburn's product
mix comes from sales of aftermarket products (e.g., consumables),
which have gross profit margins lower than equipment sales.

Service  gross  profit margins were lower in  this  year's  third
quarter and higher in this year's first nine months. The year-to-
date increase was caused primarily by the elimination of the  low
service  margins of the Company's imaging and inspection  systems
product  class,  which was included in last year's  results.  The
third  quarter comparison was affected by the heavier utilization
of  service  personnel  in  the  prior  year  to  assist  in  new
installation of automated cutting systems.

Selling,  general,  and administrative expenses  in  this  year's
third  quarter  and first nine months rose by  $6.6  million  and
$25.3  million  from last year but declined as  a  percentage  of
revenue  to  27.6  percent and 27 percent  this  year  from  30.7
percent  and  30.6  percent last year.  The  Spandex  and  Coburn

<PAGE 17>

acquisitions were the principal reasons for the dollar  increase,
while the sale of the imaging and inspection system product class
was  an  offsetting factor. The amortization of the  Spandex  and
Coburn  acquisition goodwill ($1.9 million and  $5.7  million  in
this  year's  third quarter and first nine months,  respectively)
was also a factor contributing to the overall dollar increase.

The Company continued to commit significant resources to research
and  the development of new products.  However, the ratio of  R&D
to revenue declined significantly this year.  R&D expense of $7.7
million in this year's third quarter and $23 million in the first
nine months was roughly the same as the prior year.  The ratio of
R&D  to  revenue declined to 5.5 percent and 5.2 percent  in  the
third quarter and first nine months this year, respectively, from
7.4  percent  in  the comparable periods last  year.   The  lower
current year ratio was caused by the higher revenue base from the
Spandex  acquisition without commensurate R&D expense as  Spandex
is  predominantly  a distribution company.  In  addition  to  the
incremental  expenses  of Coburn, R&D dollar  increases  for  the
three-  and nine-month periods ended January 31, 1999  were  also
related to the development of new sign making plotters and output
devices  ($0.1  million  and  $0.9  million,  respectively)   and
automated  cutting  systems  ($0.4  million  and  $1.2   million,
respectively). These increases were offset by the elimination  of
the  Company's  imaging  and  inspection  system  product  class.
Management  anticipates that this lower ratio of R&D  expense  to
revenue will continue for the balance of the current year.

Compared  to  the prior year, other income in this  year's  third
quarter  was  slightly higher, while lower for  the  nine  months
ended   January  31,  1999.  The  year-to-year  decrease  related
primarily  to  a  prior year gain of approximately  $1.6  million
($.04 per diluted share) from the final settlement of outstanding
patent litigation.

Interest expense increased $2.5 million and $8.8 million  in  the
three-  and  nine-month periods ended January 31,  1999  compared
with  the  prior  year periods. These increases  were  caused  by
significantly higher debt balances to finance the acquisition  of
Spandex.   Most of these borrowings were against a  $235  million
revolving multi-currency credit facility.  The interest  rate  on
these borrowings is variable and is based on the London Interbank
Offered Rate (LIBOR) for the relevant currency and term,  plus  a
margin  based  on the relationship of the Company's  consolidated
total   debt   to   EBITDA  (earnings  before  interest,   taxes,
depreciation, and amortization).

The provision rate for income taxes was 36.6 percent for the nine
months  ended January 31, 1999 compared with 32.1 percent in  the
comparable prior year period.  The higher tax rate this year  was
primarily the result of the goodwill amortization related to  the
acquisitions  of Spandex and Coburn, which is not deductible  for
Federal and state income tax purposes.  The year-to-year increase
in  the  provision rate also reflects the higher marginal  income

<PAGE 18>

tax  rates  associated with higher levels of pre-tax earnings  in
the current year and the liquidation of the Company's investments
in tax-exempt municipal securities.

Net earnings increased in this year's third quarter to $7 million
or  $.31  diluted  earnings per share from $6.2 million  or  $.27
diluted earnings per share in last year's third quarter.  For the
first  nine  months,  net earnings this year increased  to  $21.5
million or $.93 per diluted share compared with $16.3 million  or
$.70  per  diluted share last year. Earnings per  share  in  last
year's  first quarter and nine months included $.04  per  diluted
share from the patent litigation settlement.

YEAR 2000

The  Company recognizes the business risks posed by the Year 2000
computer date issue.  The Company continues to make this issue  a
top  business  priority and is actively working  to  control  the
associated  risks.  Each  Gerber  Scientific  business  unit  has
project  teams  to address the impact of the Year 2000  on  their
products  and  facilities, internal systems, key  suppliers,  and
customers.   These project teams are responsible  for  Year  2000
awareness,    assessment,   remediation,   testing,   contingency
planning,  and reporting to business unit senior management.   In
addition,  the  Company  has  a  Year  2000  Corporate  Oversight
Committee  that reports to Executive Management and to the  Board
of Directors.

The  Company has completed its Year 2000 awareness and assessment
phases.  The Company is  in the  process of carrying out the
remediation and testing  phases, which are expected to be
substantially completed by May 1, 1999.

Testing  of manufactured products, including internally developed
software, has been completed.  The results  of  this  testing are
being communicated  to  customers through the Company's web sites.

Some  of  the Company's internal systems are third party software
packages  which were implemented without modification.  In  these
instances,  only software upgrades were required  for  Year  2000
remediation,  which  are  now being  tested.   Additionally,  the
Company  is  implementing an enterprise resource planning  system
across   each   of   its   businesses.   Although   this   system
implementation is a direct result of a key management  initiative
to  install  improved  business processes, it  also  enables  the
remediation  of certain legacy systems in one business  that  are
not Year 2000 compliant.

The  Company  is also taking steps to understand  the  Year  2000
risks  of  its significant suppliers and customers.  As  part  of
that  process,  the Company sent questionnaires to third  parties
and is analyzing the responses.  Further analysis, including site
visits,  will be conducted as necessary.  The Company is  working
directly  with  its  key  suppliers and customers  to  avoid  any

<PAGE 19>

business  interruptions.   As  issues  arise  in  this  analysis,
contingency  plans are being developed.  Despite  these  efforts,
the  Company can provide no assurance that supplier and  customer
Year  2000  plans  will  be successfully completed  in  a  timely
manner.

Year  2000  expenditures, which are not expected to be  material,
are  planned to be incurred by April 30, 1999 and funded  through
operating  cash  flows.   The schedule  for  completion  and  the
estimated  associated costs are based on management's  estimates,
which  include  assumptions of future events.  There  can  be  no
assurance  that the Company and its suppliers and customers  will
be  fully  Year 2000 compliant by January 1, 2000.  The  Company,
therefore, could be adversely impacted by such things as loss  of
revenue,  production delays, lack of third party  readiness,  and
other   business  interruptions.  Accordingly,  the  Company   is
developing  contingency plans to address potential issues,  which
include  identification  of alternate  suppliers.   The  ultimate
effects on the Company or its suppliers or customers of not being
fully  Year 2000 compliant is not reasonably estimable.  However,
the  Company believes its Year 2000 remediation efforts, together
with  the  diverse  nature  of its businesses,  help  reduce  the
potential impact of noncompliance to levels that will not have  a
material  adverse  impact on its financial position,  results  of
operations, or cash flows.

EURO CONVERSION

On  January  1,  1999, certain member countries of  the  European
Union  established fixed conversion rates between their  existing
currencies and the European Union's common currency (Euro).   The
transition  period  for the introduction  of  the  Euro  will  be
between  January  1, 1999 and January 2, 2002.  The  Company  has
begun  to identify and ensure that all Euro conversion compliance
issues  are addressed.  At this time, the Company cannot  predict
the  impact of the Euro conversion because of numerous associated
uncertainties, such as the effect on the Company of noncompliance
by third parties.

FORWARD-LOOKING STATEMENTS

This report includes forward-looking statements that describe the
Company's  business  prospects.   Readers  should  keep  in  mind
factors  that  could have an adverse impact on  those  prospects.
These  include political, economic, or other conditions, such  as
recessionary  or  expansive  trends,  inflation  rates,  currency
exchange  rates,  taxes,  regulations  and  laws  affecting   the
business, as well as product competition, pricing, the degree  of
acceptance of new products in the marketplace, and the difficulty
of forecasting sales at various times in various markets.


<PAGE 20>

                   PART II - OTHER INFORMATION

      

Item 6.  Exhibits and Reports on Form 8-K

(a)  Exhibits

     (3.1) Restated Certificate of Incorporation of the Company.
     
     (3.2) Restated By-Laws of the Company.

     (15)  Letter    regarding   unaudited   interim    financial
           information.

     (27)  Financial data schedule.

(b)  Reports on Form 8-K

     No  Form  8-K  was filed during the quarter for  which  this
     report is filed.

<PAGE 21>

                            SIGNATURE


Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned, thereunto duly authorized.




                               GERBER SCIENTIFIC, INC.
                              ------------------------
                                    (Registrant)




Date:   March 1, 1999       By:  /s/ Gary K. Bennett
        ------------------       --------------------------------
                                 Gary K. Bennett
                                 Senior Vice President, Finance
                                 and Principal Financial Officer

<PAGE 22>

                          EXHIBIT INDEX




Exhibit Index                                                 
    Number                    Exhibit                       Page
-------------                 -------                       ----
                                                      
     3.1        Restated Certificate of  
                Incorporation of the Company.*
                                                      
     3.2        Restated By-Laws of the Company.*     
                                                      
      15        Letter  Regarding Unaudited  Interim          
                Financial Information.*
                                                      
      27        Financial Data Schedule.*             




*Filed herewith.